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Sotiria Hospital, Athens, Greece 
Tumour necrosis factor (TNF) and interleukin-1 (IL-l) are powerful mediators with a key role in 
inflammation. This study was undertaken to study the presence of TNF and IL-l in tuberculous effusion 
where there is marked inflammation and where examination of the pleural fluid may give information about 
the local inflammatory reaction. Adenosine deaminase activity (ADA, a marker of TB pleurisy) was also 
tested. Tumour necrosis factor, IL-I and ADA levels were measured in the pleural fluid and serum of 97 
patients; 33 with tuberculous effusion, 33 with malignant effusion, and 31 patients with benign non- 
tuberculous effusion. Pleural fluid TNF and ADA levels were higher in tuberculous (TB) patients than in 
patients with benign disorders or cancer (WO.01). Serum TNF levels were also higher in TB patients than 
other benign (WO.01) or malignant (P<O.O5) effusions. There was a positive correlation between serum and 
pleural fluid values (r=0.998-0.999, P<O.OOl) although pleural fluid concentration was higher (P<O.OOl), 
possibly suggesting local production in the pleural cavity. Pleural fluid IL-l levels were not raised in any 
patient group but there was a positive correlation between TNF and IL-I. In addition, a positive correlation 
was found between TNF and ADA levels, probably indicating some common production mechanism. 
Furthermore, ADA sensitivity in the diagnosis of tuberculous effusion was augmented by the combined use of 
TNF and ADA. The use of both these markers may prove useful in the differential diagnosis of TBC pleurisy. 
Introduction 
Tuberculosis has always been a serious health 
problem world-wide and although there is effec- 
tive therapy, epidemiological data show a rise in 
incidence, especially since AIDS incidence rose 
steeply. 
Hosts fight tuberculosis through cell-mediated 
immunity. An example of successful cell-mediated im- 
munity is tuberculous effusion, where although there 
is marked inflammation often resulting in marked 
scarring of the pleura, local immunity is usually strong 
enough to eliminate the pleuritic response. 
Two cytokines - tumour necrosis factor (TNF) 
and interleukin-1 (IL-l) ~ are powerful inflammatory 
mediators and probably play a key role in the local 
pleuritic reaction. Both cytokines also cause many 
systemic effects like fever and production of acute 
phase proteins. 
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There is evidence that TNF is found in high 
concentration in tuberculous (TBC) pleural effusion 
(1) and this could explain systemic and local reac- 
tions. However, since TNF induces IL-l synthesis, 
many of these effects may be due to the presence of 
IL-1 and this has been implicated in some studies (2). 
Both of these cytokines act on T-cells and percent- 
ages of CD3+ and CD4+ T-cells are greater in TB 
effusion (3,4). Adenosine deaminase activity (ADA) 
is also higher in TBC effusions (5,6) and a positive 
correlation between CD4+ counts and ADA activity 
has been reported (7). 
Today, ADA is used as a marker of tuberculous 
effusion (6,s) and it would be interesting to test 
whether TNF or IL-1 could also be used as indicators 
of tuberculous effusion. Although some studies show 
high concentration of TNF, others show no signifi- 
cant difference between TNF concentration in TB 
and non-TB pleural effusion (1,9). 
This study was undertaken to study the presence of 
TNF, IL-l and ADA in tuberculous effusion and to 
compare it with the concentrations of these cytokines 
in non-TBC benign effusions and malignant effusions 
where TNF is thought to play a major role. 
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Fig. I Levels of tumour necrosis factor in serum (s) and 
pleural fluid (pf) of patients suffering from benign non- 
tuberculous, cancerous, and tuberculous effusion. *P<O.O5, 
**p<o.o1, ***p<o.o01. 
Materials and Methods 
PATIENT POPULATION 
Pleural fluid and serum were obtained from 97 
patients. According to their final diagnoses, the 
patients were divided into three groups. 
(1) Thirty-three patients, 21 male and 12 female, 
aged 21-64 years, with tuberculous pleural 
effusion, newly diagnosed. The diagnosis was 
confirmed by pleural biopsy or/and bacterio- 
logic findings. 
(2) Thirty-three patients with malignant pleural 
effusion, 25 male and eight female, aged 38-75 
years. Cytologic examination of the pleural 
fluid showed 22 adenocarcinomas, five 
squamous cell carcinomas, four small cell 
carcinomas and two mesotheliomas. 
(3) Thirty-one patients, 23 male and eight female, 
aged 25-82 years, with benign non-tuberculous 
effusion. Ten of the patients were parapneu- 
manic, eight cases were viral, eight cases were 
due to heart failure, and five cases were due to 
pulmonary embolism. 
METHOD 
Samples of pleural fluid and peripheral blood were 
centrifuged at 3000 rpm for 15 min to pellet the 
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Fig. 2 Levels of adenosine deaminase activity in serum (s) 
and pleural fluid (pf) of patients suffering from benign 
non-tuberculous, cancerous, and tuberculous effusion. 
*f-0.05, **p<o.o1, ***P<o.ool. 
cellular elements. Samples were frozen at - 20°C 
until assayed. Concentrations of TNF and IL-l were 
measured by radioimmunoassay (Biotra RPA 
Amersham and Farmos, respectively) and ADA 
activity was determined by the Giusty calorimetric 
method. 
STATISTICAL ANALYSIS 
Groups were compared by the Mann-Whitney 
rank sum test. Correlations between different 
markers were performed using Pearson product 
moment correlation. 
Results 
Tumour necrosis factor, IL-l and ADA concen- 
trations in the pleural fluid group of patients, are 
shown in Figs l-3. 
Serum (TNFs) levels in TB patients were sig- 
nificantly higher than those in patients with 
benign disorders other than TB (19.7 f 24.9 vs. 
5.4 k 2.7 pg ml - ‘, PcO.01) and in patients with 
cancer (19.7 f 24.9 vs. 7.4 & 9.7 pg ml- ‘, PcO.05). 
Pleural fluid (TNFpf) levels in TBC patients were 
significantly higher than those patients with benign 
disorders other than TB or with cancer 100.3 f 102 
vs. 10.4 & 15 and 17.7 f 37.6 pg ml - i respectively, 
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Fig. 3 Levels of interleukin-I in serum (s) and pleural fluid 
(pf) of patients suffering from benign non-tuberculous, 
cancerous, and tuberculous effusion. *P<O.OS, **P<O.Ol, 
***P<o.ool. 
P<O.OOl). Pleural fluid TNF levels in TB patients 
were also significantly higher than serum TNF levels 
(100.3 f 102 vs. 19.7 f 24.9 pg ml- ‘, P<O.OOl). A 
positive correlation was found between TNFs and 
TNFpf in all studied groups (r-=0.9984999, 
P<O.OOl). 
Serum ADA levels were higher in TB patients than 
in patients with benign disorders other than TB 
(36.3 & 22.7 vs. 22 & 8.7 U/L, P<O.OOl), but not in 
patients with cancer (36.3 f 22.7 vs. 27.3 f 11.6 U/L, 
P>O.O5). Pleural fluid ADA levels were also higher in 
TB patients than in patients with benign disorders 
other than TB and in patients with cancer 
(85.6 f 48.9 V.Y. 23.6 f 8.5 and 27.7 f 12.5 U/L 
respectively, PcO.001). There was no correlation 
between ADAs and ADApf levels in all studied 
group of patients. 
Serum IL-l (IL-1s) levels in TB patients were 
higher than those in patients with benign disorders 
other than TB (1.4 f 0.7 vs. 1 f 0.6, P<O.O5), but not 
than those in cancer patients (1.4 f 0.7 vs. 1.5 k 1.9, 
P>O.O5). Pleural fluid IL-l levels were not raised in 
any patient group. There was, however, a positive 
correlation between IL-1s and IL-lpf in TB patients 
(t-=0.873, P<O*OOl). Furthermore, in the same group 
of patients, a positive correlation was found between 
IL-lpf and TNFpf levels (r=0.923, P<O.OOl). 
Using the mean concentration plus two standard 
deviations (mean f 2s~) as cut-off values in patients 
with benign disorders other than TB, sensitivity, 
specificity and accuracy of ADA and TNF in TB and 
cancer patients are shown in Table 1. Briefly, in TB 
patients, ADApf and TNFpf showed the highest 
sensitivity, specificity and accuracy. When ADApf 
and TNFpf were combined together, sensitivity and 
accuracy were even higher without significant 
decreases in specificity. 
Discussion 
There is considerable evidence to suggest that 
many of the metabolic, biochemical and haemato- 
logic effects of infection and cancer are due to 
cytokines such as TNF and IL-l. 
In this study, high levels of TNF were found in 
patients with TB pleurisy. Tumour necrosis factor 
was concentrated 2- to 51-fold (mean 15-fold) in 
pleural fluid, compared to the blood of the same 
patients. This may indicate that TNF is produced 
locally in the pleural cavity and that there is a 
spill-over effect causing a rise in blood concentration. 
Indeed, in patients with TB pleurisy and high TNF 
levels, Barnes et al. detected messenger RNA for 
TNF in pleural tissue by in situ hybridization 
suggesting local production (I). 
It is well known that activated macrophages and 
T-cells play a central role in TB immunity. Studies on 
macrophages have shown that once activated, usually 
with INF-y, they produce TNF, IL-l, GM-CSF and 
Table I Sensitivity, specificity and accuracy of adenosine deaminase activity (ADA) and 
tumour necrosis factor (TNF) in cancer (CA) and tuberculosis (TB) patients 
Sensitivity (%) Specificity (%) 
CA TB CA TB 
Accuracy (%) 
CA TB 
sTNF (r27 ml - ‘) pg 0 21 96.7 96.7 47 58 
sADA (239.4 U/L) 9 33 93.5 93.5 50 62.5 
pffNF (>40.4pgml-‘) 9 70 93-5 93.5 50 81 
pfADA (>40.6 U/L) 9 79 93.5 93.5 50 86 
pfADA+pflNF 15 88 90 90 51.5 89 
pf, pleural hid; s, serum. 
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Mq-CSF. Studies on cellular kinetics and cytokine 
production in TB pleurisy showed a dense, predomi- 
nantly CD4+ T-cell infiltration (3). It has also been 
found that CD4+ cells (mainly THl) produce TNF 
but not IL-l (10). Therefore, both activated macro- 
phages and CD4+ T-cells may be the sources of the 
high levels of TNF in TB pleural effusion. 
Although TNF has been reported as a cytokine 
involved in cancer, increased mean TNF levels were 
not found in cancer patients. It is worthy of mention 
that three patients with adenocarcinomas had high 
TNF levels both in pleural fluid and serum. High 
levels of TNF in adenocarcinomas have also been 
reported previously but the mechanisms of this 
reaction are unknown (11). 
Tumour necrosis factor is known to induce IL-l 
production from macrophages and endothelial cells. 
In this study, no rise in pleural fluid IL-1 levels was 
noted in any tested group of patients. Nevertheless, 
there was a strong correlation between pleural fluid 
IL-l and TNF levels in TB patients. Low levels of 
IL-l could indicate a transient rise in IL-I production 
that was no longer present when tested. A recent 
study of the kinetics of cytokine mRNAs showed a 
different time-course of TNF and IL-l mRNAs (12). 
Increased ADA activity is present in several con- 
ditions but mainly in TB, rheumatoid arthritis, 
lymphoproliferative disorders and empyema. Never- 
theless, today ADA is considered to be a very 
useful and reliable marker of TB pleurisy. The results 
of this study confirmed the usefulness of ADA in 
discriminating TB from non-TB pleural effusions 
(6-8,13). 
High levels of ADA in TB pleural effusion may 
indicate CD4 T-cell activation. Adenosine deaminase 
activity is considered to rise with T-cell prolification 
(6) and indeed TB pleural effusions were shown to 
have high numbers of CD3+, CD4+ and CD8 + 
T-cells compared to non-TB effusions (7). Further- 
more, a positive correlation between pleural fluid 
ADA and TNF was found in TB patients. This fact 
may indicate a common production mechanism for 
TNF and ADA that needs further investigation. 
In conclusion, TNF seems to be a good marker 
of TB pleurisy, and its use combined with the use 
of ADA may increase sensitivity in diagnosing 
tuberculous pleural effusions. 
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